Search This Blog

Monday, July 13, 2020

Pandion Therapeutics sets terms for upsized IPO

Pandion Therapeutics (PAND) has filed a preliminary prospectus for its IPO of 5.5M common shares at $16 – 18, expected to yield $93.5M (midpoint), up from its initial filing for a $75M offering.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)